Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
123
Journal Issue
8
Pages
891 - 898
Date Issued
2024-02-28
Author(s)
Abstract
Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) reduce the risk of hepatocellular carcinoma (HCC) in patients of hepatitis B. This study compared the difference between ETV and TDF on risk of HCC recurrence and mortality in patients with HBV-related HCC after curative intent treatment.
Subjects
Hepatitis B virus; Liver neoplasm; Prognosis; Radiofrequency ablation; Surgery
SDGs
Type
journal article